Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 281
Selected: 0
NCT IDTitle
NCT04202445TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction
NCT02392130A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
NCT02580773Therapeutic Anticoagulation Strategy for Acute Chest Syndrome
NCT03336372Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
NCT02748902Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.
NCT00051545Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
NCT00216879Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
NCT01052467Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
NCT00626795Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
NCT02354391Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis
NCT03508856Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
NCT01703078Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
NCT05388760Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
NCT05098821Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
NCT01707043Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris
NCT02424305Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions
NCT00475605A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
NCT01607853A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris
NCT01297166A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris
NCT03669757Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
NCT01141179The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847
NCT00851864Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing
NCT00506519Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
NCT01449513PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
NCT03231124Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.
NCT01866163LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
NCT01037881LEO 29102 Cream in the Treatment of Atopic Dermatitis
NCT04922021An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
NCT01761019A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
NCT03826901Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children
NCT01707368Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
NCT01422434LEO 90105 Ointment in Japanese Subjects With Psoriasis
NCT04765332Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT01423656Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102
NCT03478280Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis
NCT02496546An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
NCT01935869Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100
NCT01310049LEO 32731 - A Study in Healthy Male Subjects
NCT02577185An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A
NCT00392067LEO19123 Cream in the Treatment of Atopic Dermatitis
NCT00408330A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
NCT02533973Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
NCT00279162Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
NCT01461655Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris
NCT00711308Tinzaparin in the Treatment of the Acute Pulmonary Embolism
NCT05682976Ophthalmological Adverse Events of Tralokinumab in AD
NCT03131648Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
NCT02379793Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
NCT01922050A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
NCT02856542Real-life Evaluation of the Daivobet® Gel Applicator